G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 145 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 145 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 145 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 145 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 145 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 145 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 145 | +101.4% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 72 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 72 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 72 | -66.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 212 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 212 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -66.7% | 212 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 212 | -10.9% | 0.00% | – |
| Q3 2019 | $5,000 | -28.6% | 238 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | +75.0% | 238 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 238 | +51.6% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 157 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | +14.3% | 157 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 157 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | – | 157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
| EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
| Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
| Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
| Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
| Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
| BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |